These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 9667562

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differential alteration of the nigrostriatal dopaminergic system in Wilson's disease investigated with [123I]ss-CIT and high-resolution SPET.
    Barthel H, Sorger D, Kühn HJ, Wagner A, Kluge R, Hermann W.
    Eur J Nucl Med; 2001 Nov; 28(11):1656-63. PubMed ID: 11702107
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB.
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [Abstract] [Full Text] [Related]

  • 5. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
    Ishikawa T, Dhawan V, Kazumata K, Chaly T, Mandel F, Neumeyer J, Margouleff C, Babchyck B, Zanzi I, Eidelberg D.
    J Nucl Med; 1996 Nov; 37(11):1760-5. PubMed ID: 8917170
    [Abstract] [Full Text] [Related]

  • 6. SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction.
    Sakakibara R, Shinotoh H, Uchiyama T, Yoshiyama M, Hattori T, Yamanishi T.
    J Neurol Sci; 2001 Jun 15; 187(1-2):55-9. PubMed ID: 11440745
    [Abstract] [Full Text] [Related]

  • 7. [Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms].
    Bettin S, Kämpfer I, Seese A, Schäfer A, Reuter M, Lössner J, Dietrich J, Wagner A, Knapp WH.
    Nuklearmedizin; 1997 Aug 15; 36(5):167-72. PubMed ID: 9380528
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, Stoof JC, Wolters EC.
    J Nucl Med; 1998 Jul 15; 39(7):1143-8. PubMed ID: 9669384
    [Abstract] [Full Text] [Related]

  • 10. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.
    Booij J, Speelman JD, Horstink MW, Wolters EC.
    Eur J Nucl Med; 2001 Mar 15; 28(3):266-72. PubMed ID: 11315592
    [Abstract] [Full Text] [Related]

  • 11. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
    Eising EG, Müller TT, Zander C, Kuhn W, Farahati J, Reiners C, Coenen HH.
    J Investig Med; 1997 Oct 15; 45(8):448-52. PubMed ID: 9394097
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.
    Asenbaum S, Brücke T, Pirker W, Podreka I, Angelberger P, Wenger S, Wöber C, Müller C, Deecke L.
    J Nucl Med; 1997 Jan 15; 38(1):1-6. PubMed ID: 8998140
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
    Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AG, Wolters EC, van Royen EA.
    J Neurol Neurosurg Psychiatry; 1997 Feb 15; 62(2):133-40. PubMed ID: 9048712
    [Abstract] [Full Text] [Related]

  • 17. The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography.
    Snow BJ, Bhatt M, Martin WR, Li D, Calne DB.
    J Neurol Neurosurg Psychiatry; 1991 Jan 15; 54(1):12-7. PubMed ID: 1901347
    [Abstract] [Full Text] [Related]

  • 18. [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression.
    Marek K, Innis R, van Dyck C, Fussell B, Early M, Eberly S, Oakes D, Seibyl J.
    Neurology; 2001 Dec 11; 57(11):2089-94. PubMed ID: 11739831
    [Abstract] [Full Text] [Related]

  • 19. Imaging the pre- and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: a SPECT study using [123I] epidepride and [123I] beta-CIT.
    Naumann M, Pirker W, Reiners K, Lange KW, Becker G, Brücke T.
    Mov Disord; 1998 Mar 11; 13(2):319-23. PubMed ID: 9539347
    [Abstract] [Full Text] [Related]

  • 20. Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease.
    Andringa G, Drukarch B, Bol JG, de Bruin K, Sorman K, Habraken JB, Booij J.
    Neuroimage; 2005 Jul 15; 26(4):1150-8. PubMed ID: 15908232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.